A
$ Value
$0
Shares
18,471
Price
$0
Filed
Dec 16
Insider
Name
Pauza Charles David
Title
Chief Science Officer Virology
CIK
0002018150
Roles
Officer
Transaction Details
Transaction Date
2025-12-12
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
115,971
Footnotes
Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis. | The options vest 100% on the first anniversary of the grant date.
Filing Info
Pauza Charles David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-08 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-10-12 | TRAW | A | $0 |
Other Insiders at TRAW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| STOVER JACK E | — | — | 2026-03-08 |
| CAUTREELS WERNER | — | — | 2026-03-08 |
| Leaman John Harold | — | — | 2026-03-08 |
|
Dukes Iain D.
Chief Executive Officer
|
— | — | 2026-03-08 |
| Shoemaker Mary Teresa | — | — | 2026-03-08 |
| Clarke Trafford | — | — | 2026-03-08 |
|
Savchuk Nikolay
Chief Operating Officer
|
— | — | 2026-03-08 |
|
Pauza Charles David
Chief Science Officer Virology
|
— | — | 2026-03-08 |
|
Redfield Robert
Chief Medical Officer
|
— | — | 2026-03-08 |
|
Parker Charles Nolan
Chief Financial Officer
|
— | — | 2026-03-08 |